Reproducible grey matter patterns index a multivariate, global alteration of brain structure in schizophrenia and bipolar disorder.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
17 01 2019
Historique:
received: 04 07 2018
accepted: 16 07 2018
entrez: 22 1 2019
pubmed: 22 1 2019
medline: 21 5 2019
Statut: epublish

Résumé

Schizophrenia is a severe mental disorder characterized by numerous subtle changes in brain structure and function. Machine learning allows exploring the utility of combining structural and functional brain magnetic resonance imaging (MRI) measures for diagnostic application, but this approach has been hampered by sample size limitations and lack of differential diagnostic data. Here, we performed a multi-site machine learning analysis to explore brain structural patterns of T1 MRI data in 2668 individuals with schizophrenia, bipolar disorder or attention-deficit/ hyperactivity disorder, and healthy controls. We found reproducible changes of structural parameters in schizophrenia that yielded a classification accuracy of up to 76% and provided discrimination from ADHD, through it lacked specificity against bipolar disorder. The observed changes largely indexed distributed grey matter alterations that could be represented through a combination of several global brain-structural parameters. This multi-site machine learning study identified a brain-structural signature that could reproducibly differentiate schizophrenia patients from controls, but lacked specificity against bipolar disorder. While this currently limits the clinical utility of the identified signature, the present study highlights that the underlying alterations index substantial global grey matter changes in psychotic disorders, reflecting the biological similarity of these conditions, and provide a roadmap for future exploration of brain structural alterations in psychiatric patients.

Identifiants

pubmed: 30664633
doi: 10.1038/s41398-018-0225-4
pii: 10.1038/s41398-018-0225-4
pmc: PMC6341112
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

12

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : R01 MH062873
Pays : United States
Organisme : NIBIB NIH HHS
ID : U54 EB020403
Pays : United States
Organisme : Medical Research Council
Pays : United Kingdom

Références

Neuroimage. 2006 Aug 15;32(2):511-9
pubmed: 16677830
Nat Genet. 2013 Sep;45(9):984-94
pubmed: 23933821
Biol Psychiatry. 2008 Nov 1;64(9):774-81
pubmed: 18486104
Brain. 2015 Jul;138(Pt 7):2059-73
pubmed: 25935725
Neuroimage. 2014 Jan 1;84:299-306
pubmed: 24004694
Neuroimage. 1999 Feb;9(2):179-94
pubmed: 9931268
Neuron. 2002 Jan 31;33(3):341-55
pubmed: 11832223
Br J Psychiatry. 2012 Apr;200(4):268-9
pubmed: 22474230
World Psychiatry. 2016 Jun;15(2):179-80
pubmed: 27265711
Psychiatry Res. 2014 Jan 30;221(1):69-77
pubmed: 24239093
Biol Psychiatry. 2011 May 15;69(10):936-44
pubmed: 21195390
Neuron. 2006 Oct 5;52(1):139-53
pubmed: 17015232
Science. 2018 Jun 22;360(6395):
pubmed: 29930110
J Clin Psychiatry. 2007 Nov;68(11):1776-84
pubmed: 18052572
Schizophr Bull. 2018 Aug 20;44(5):1035-1044
pubmed: 29186619
Neuroimage. 2000 Jun;11(6 Pt 1):805-21
pubmed: 10860804
Epidemiol Rev. 2008;30:67-76
pubmed: 18480098
BMC Bioinformatics. 2007 Sep 03;8:328
pubmed: 17767709
Psychol Med. 2006 Nov;36(11):1501-14
pubmed: 16817986
Psychopharmacol Bull. 1995;31(2):347-51
pubmed: 7491390
Neuroimage. 2002 Jan;15(1):273-89
pubmed: 11771995
Mol Psychiatry. 2016 Apr;21(4):585
pubmed: 26283641
JAMA Psychiatry. 2017 Dec 1;74(12):1183-1184
pubmed: 29094160
Neuron. 2000 Nov;28(2):325-34
pubmed: 11144342
Schizophr Bull. 2015 Sep;41(5):1133-42
pubmed: 25548384
Schizophr Bull. 2017 Jul 1;43(4):914-924
pubmed: 27872268
Schizophr Bull. 2013 Sep;39(5):1129-38
pubmed: 23042112
Mol Psychiatry. 2018 Jun;23(6):1512-1520
pubmed: 28507318
Nat Genet. 2017 Jan;49(1):152-156
pubmed: 27918536
BMC Bioinformatics. 2009 Jul 10;10:213
pubmed: 19591666
Neuroimage Clin. 2017 Jun 09;15:719-731
pubmed: 28702349
J Affect Disord. 2010 Jul;124(1-2):1-8
pubmed: 19683348
J Clin Psychiatry. 2010 Feb;71(2):e05
pubmed: 20193644
Neuroimage. 2006 Jul 1;31(3):968-80
pubmed: 16530430
BMC Bioinformatics. 2011 Mar 17;12:77
pubmed: 21414208
Neurosci Biobehav Rev. 2012 Apr;36(4):1342-56
pubmed: 22244985
Biol Psychiatry. 2012 May 15;71(10):855-63
pubmed: 22244831
Cereb Cortex. 2004 Jan;14(1):11-22
pubmed: 14654453
Arch Gen Psychiatry. 2005 Apr;62(4):361-70
pubmed: 15809403
Nature. 2009 Aug 6;460(7256):748-52
pubmed: 19571811
PLoS One. 2017 Feb 6;12(2):e0171595
pubmed: 28166306
Neuroimage. 2007 Oct 15;38(1):95-113
pubmed: 17761438
Psychiatry Res. 2005 Aug 30;139(3):229-38
pubmed: 16055311
Neuroinformatics. 2015 Jan;13(1):31-46
pubmed: 25048627
PLoS One. 2017 Apr 20;12(4):e0175683
pubmed: 28426817
Am J Psychiatry. 2005 Dec;162(12):2233-45
pubmed: 16330585
Mol Psychiatry. 2016 Oct;21(10):1460-6
pubmed: 26782053
Schizophr Res. 2011 Apr;127(1-3):46-57
pubmed: 21300524
Neurosci Biobehav Rev. 2015 Oct;57:328-49
pubmed: 26254595
Am J Psychiatry. 2008 Aug;165(8):1015-23
pubmed: 18381902
Front Neurosci. 2014 Aug 20;8:229
pubmed: 25191215

Auteurs

Emanuel Schwarz (E)

Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany. emanuel.schwarz@zi-mannheim.de.

Nhat Trung Doan (NT)

Norwegian Centre for Mental Disorders Research (NORMENT), KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Giulio Pergola (G)

Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy.

Lars T Westlye (LT)

Norwegian Centre for Mental Disorders Research (NORMENT), KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Psychology, University of Oslo, Oslo, Norway.

Tobias Kaufmann (T)

Norwegian Centre for Mental Disorders Research (NORMENT), KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Thomas Wolfers (T)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Donders Center for Cognitive Neuroimaging, Radboud University, Nijmegen, The Netherlands.

Ralph Brecheisen (R)

Maastricht University Medical Center, Maastricht, The Netherlands.

Tiziana Quarto (T)

Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy.
Cognitive Brain Research Unit, Department of Psychology and Logopedics, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Alex J Ing (AJ)

Centre for Population Neuroscience and Stratified Medicine (PONS) and MRC-SGDP Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Pasquale Di Carlo (P)

Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy.

Tiril P Gurholt (TP)

Norwegian Centre for Mental Disorders Research (NORMENT), KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Robbert L Harms (RL)

Brain Innovation B.V., Maastricht, The Netherlands.

Quentin Noirhomme (Q)

Brain Innovation B.V., Maastricht, The Netherlands.

Torgeir Moberget (T)

Norwegian Centre for Mental Disorders Research (NORMENT), KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Ingrid Agartz (I)

Norwegian Centre for Mental Disorders Research (NORMENT), KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm County Council, Stockholm, Sweden.
Department of Psychiatry Research, Diakonhjemmet Hospital, Oslo, Norway.

Ole A Andreassen (OA)

Norwegian Centre for Mental Disorders Research (NORMENT), KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Marcella Bellani (M)

Section of Psychiatry, Azienda Ospedaliera Universitaria Integrata Verona, Verona, VR, Italy.
Department of Neurosciences, Biomedicine and Movements Sciences, University of Verona, Verona, VR, Italy.

Alessandro Bertolino (A)

Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy.
Institute of Psichiatry, Policlinico Bari, Azienda Ospedaliero Universitaria Consorziale Policlinico Bari, Bari, BA, Italy.

Giuseppe Blasi (G)

Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy.
Azienda Ospedaliero-Universitaria Consorziale Policlinico, Bari, Italy.

Paolo Brambilla (P)

Department of Neurosciences and Mental Health, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.

Jan K Buitelaar (JK)

Donders Institute for Brain, Cognition and Behaviour, Radboudumc, Nijmegen, The Netherlands.
Karakter Child and Adolescent Psychiatry University Center, Nijmegen, The Netherlands.

Simon Cervenka (S)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm County Council, Stockholm, Sweden.

Lena Flyckt (L)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm County Council, Stockholm, Sweden.

Sophia Frangou (S)

Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Barbara Franke (B)

Donders Institute for Brain, Cognition and Behaviour, Radboudumc, Nijmegen, The Netherlands.
Departments of Human Genetics and Psychiatry, Radboud University Medical Center, Nijmegen, The Netherlands.

Jeremy Hall (J)

Neuroscience and Mental Health Research Institute, Cardiff University, Maindy Road, Cardiff, CF24 4HQ, UK.

Dirk J Heslenfeld (DJ)

Department of Cognitive Psychology, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Peter Kirsch (P)

Department of Clinical Psychology, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany.
Bernstein Center for Computational Neuroscience Heidelberg-Mannheim, Mannheim, Germany.

Andrew M McIntosh (AM)

Division of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, EH10 5HF, UK.
Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, George Square, Edinburgh, EH8 9JZ, UK.

Markus M Nöthen (MM)

Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany.
Department of Genomics, Life & Brain Center, University of Bonn, Bonn, Germany.

Andreas Papassotiropoulos (A)

Division of Molecular Neuroscience, Department of Psychology, University of Basel, CH-4055, Basel, Switzerland.
Transfaculty Research Platform Molecular and Cognitive Neuroscience, University of Basel, Basel, Switzerland.
Psychiatric University Clinics, University of Basel, CH-4055, Basel, Switzerland.
Department Biozentrum, Life Sciences Training Facility, University of Basel, CH-4056, Basel, Switzerland.

Dominique J-F de Quervain (DJ)

Transfaculty Research Platform Molecular and Cognitive Neuroscience, University of Basel, Basel, Switzerland.
Psychiatric University Clinics, University of Basel, CH-4055, Basel, Switzerland.
Division of Cognitive Neuroscience, Department of Psychology, University of Basel, CH-4055, Basel, Switzerland.

Marcella Rietschel (M)

Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.

Gunter Schumann (G)

Centre for Population Neuroscience and Stratified Medicine (PONS) and MRC-SGDP Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Heike Tost (H)

Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

Stephanie H Witt (SH)

Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.

Mathias Zink (M)

Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
District Hospital Mittelfranken, Department of Psychiatry, Psychotherapy and Psychosomatics, Ansbach, Germany.

Andreas Meyer-Lindenberg (A)

Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany. Andreas.Meyer-Lindenberg@zi-mannheim.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH